Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 6 December

Bell Direct
December 6, 2024

Morning Bell 5 December

Bell Direct
December 5, 2024

Morning Bell 4 December

Grady Wulff
December 4, 2024

Morning Bel 3 December

Sophia Mavridis
December 3, 2024

Morning Bell 2 December

Grady Wulff
December 2, 2024

Weekly Wrap 29 November

Bell Direct
November 29, 2024

Morning Bell 28 November

Bell Direct
November 28, 2024

Morning Bell 27 November

Bell Direct
November 27, 2024

Morning Bell 26 November

Bell Direct
November 26, 2024

Morning Bell 25 November

Bell Direct
November 25, 2024

From the helm: Bega Cheese

Grady Wulff
November 22, 2024

Morning Bell 21 November

Bell Direct
November 21, 2024